Mitochondrial protein import clogging as a mechanism of disease
eLife · 02.05.2023 · 12
DOI: 10.7554/elife.84330 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 02.05.2023. Verfasst von Liam P Coyne und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, United States. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Mitochondrial biogenesis requires the import of >1,000 mitochondrial preproteins from the cytosol. Most studies on mitochondrial protein import are focused on the core import machinery. Whether and how the biophysical properties of substrate preproteins affect overall import efficiency is underexplored. Here, we show that protein traffic into mitochondria can be disrupted by amino acid substitutions in a single substrate preprotein. Pathogenic missense mutations in ADP/ATP translocase 1 (ANT1), and its yeast homolog ADP/ATP carrier 2 (Aac2), cause the protein to accumulate along the protein import pathway, thereby obstructing general protein translocation into mitochondria. This impairs mitochondrial respiration, cytosolic proteostasis, and cell viability independent of ANT1’s nucleotide transport activity. The mutations act synergistically, as double mutant Aac2/ANT1 causes severe clogging primarily at the translocase of the outer membrane (TOM) complex. This confers extreme toxicity in yeast. In mice, expression of a super-clogger ANT1 variant led to neurodegeneration and an age-dependent dominant myopathy that phenocopy ANT1-induced human disease, suggesting clogging as a mechanism of disease. More broadly, this work implies the existence of uncharacterized amino acid requirements for mitochondrial carrier proteins to avoid clogging and subsequent disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, United States.
- Institute of Biochemistry and Molecular Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Institute of Biochemistry and Molecular Biology, Faculty of Medicine, University of Bonn, Bonn, Germany.
- Proteomics and Mass Spectrometry Core Facility, State University of New York Upstate Medical University, Syracuse, United States.
- Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, United States.
- Department of Neurology, State University of New York Upstate Medical University, Syracuse, United States.
ORCID-Profile: Liam P Coyne, Xin Jie Chen
Förderung
- NIA NIH HHS
- National Institute on Aging
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Coyne, L. P., Wang, X., Song, J., de Jong, E., Schneider, K., Massa, P. T., Middleton, F. A., Becker, T., & Chen, X. J. (2023). Mitochondrial protein import clogging as a mechanism of disease. eLife, 12. https://doi.org/10.7554/elife.84330
Vancouver
Coyne LP, Wang X, Song J, de Jong E, Schneider K, Massa PT, et al. Mitochondrial protein import clogging as a mechanism of disease. eLife. 2023;12. doi:10.7554/elife.84330
BibTeX
@article{Coyne2023,
author = {Coyne, Liam P and Wang, Xiaowen and Song, Jiyao and de Jong, Ebbing and Schneider, Karin and Massa, Paul T and Middleton, Frank A and Becker, Thomas and Chen, Xin Jie},
title = {Mitochondrial protein import clogging as a mechanism of disease},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.84330}
}
EUVIMED